• Hyperoside, DHX9, and R-Loop Resolution in URSA

  2026-09-10

  A 2026 study identifies DHX9-mediated R-loop resolution as a mechanistic link between hyperoside treatment, reduced endometrial stromal cell senescence, and improved decidualization in unexplained recurrent spontaneous abortion. Its integration of patient tissues, mouse models, and telomerase-immortalized human stromal cells provides a useful framework for studying how genome-associated stress affects endometrial receptivity.

• A 83-01: Selective ALK-5 Inhibitor Guide

  2026-09-09

  A 83-01 is a selective ALK-5 inhibitor that suppresses TGF-β-driven Smad-dependent transcription in biochemical and cellular assays. Its documented activity against ALK-4 and ALK-7, limited BMP interference at lower test concentration, and use in hESC trophoblast differentiation make it a practical research tool when assay context and vehicle controls are preserved.

• BCL6–ESM1 Immune Evasion in Hepatocellular Carcinoma

  2026-09-09

  The reference study identifies cancer-cell-derived BCL6 as a driver of hepatocellular carcinoma progression through suppression of tumor-infiltrating CD4+ T-cell activity. Its mechanistic model links BCL6 to reduced inflammatory chemokines and increased ESM1, providing a framework for studying immune evasion and for designing complementary tumor-monitoring workflows.

• Pemetrexed Workflows for Mechanism-Guided Cancer Assays

  2026-09-08

  Build reproducible antifolate assays with pemetrexed disodium by aligning concentration, exposure time, and cell-state controls. The workflow also connects folate-pathway inhibition with homologous-recombination phenotypes in non-small cell lung carcinoma research and malignant mesothelioma models.

• SCH772984: ERK1/2 Inhibitor Workflow Guide

  2026-09-08

  Build a practical SCH772984 workflow for dissecting ERK signaling, tumor-cell dependence, and radiosensitization hypotheses. The guide connects pathway pharmacology with the Ang II–HIF-1α–HILPDA ferroptosis framework while separating established product performance from testable applications in nasopharyngeal carcinoma.

• Cassava A20/AN1 Genes Under Multiple Abiotic Stresses

  2026-09-07

  This study functionally characterizes three cassava A20/AN1 genes—Metip4, Metip8, and Metip11—across drought, salinity, temperature, and metal stresses. By combining gene prediction, interaction assays, heterologous transgenics, virus-induced gene silencing, physiological measurements, and transcriptomics, the authors show both shared stress-protective functions and gene-specific responses.

• MG-132: From Proteasome Stress to Translation

  2026-09-07

  MG-132, also known as Z-LLL-al, is more than a cytotoxicity reagent: it is a cell-permeable probe for testing how proteasome-dependent protein turnover shapes apoptosis, cell-cycle control, oxidative stress, and p53 biology. This thought-leadership article connects MG-132 pharmacology with findings from the MLF2–USP7–p53 colorectal cancer study and provides a translational framework for using the compound without overstating what proteasome inhibition can prove.

• Ribonuclease R for Circular RNA Workflows

  2026-09-05

  Ribonuclease R (RNase R) (20 U/μL) enables selective linear RNA depletion for circular RNA enrichment, validation, and sequencing workflows. This guide connects practical digestion controls with the circ_0042103/TAF15/NER findings in pulpitis research.

• Ertugliflozin (PF-04971729) Research Workflows

  2026-09-04

  Build reproducible renal glucose transport, diabetes mellitus, cardiovascular, and mucosal-barrier studies with the highly selective SGLT2 inhibitor Ertugliflozin. This guide connects practical dosing and assay setup with the VERTIS CV evidence while separating translational findings from exploratory preclinical applications.

• Prednisone Workflows for PBL Immunosuppression

  2026-09-04

  Prednisone is a defined synthetic corticosteroid for modeling lymphocyte suppression, G1 arrest, IL-2 pathway changes, and apoptosis with controlled exposure variables. This practical guide connects cell-based workflows with digestive-metabolomics quality principles while clearly separating established evidence from assay-development recommendations.

• Acifran Workflows for GPCR Lipid Signaling

  2026-09-03

  Acifran enables matched HCAR2/GPR109A and HCAR3/GPR109B experiments that connect receptor activation with cAMP and lipid-pathway readouts. This practical guide translates recent cryo-EM findings into assay design, dose planning, structural validation, and troubleshooting strategies.

• S-Nitrosylation Coordinates Al Resistance in Arabidopsis

  2026-09-03

  A 2026 Molecular Plant study identifies nitric oxide–dependent S-nitrosylation as a dual regulatory mechanism linking external and internal aluminum detoxification in Arabidopsis. The work shows that modification of STOP1 and STAR1 has opposing effects on protein stability, providing a mechanistic framework for interpreting redox regulation of aluminum resistance and designing thiol-centered validation assays.

• Hoechst 33342/PI Double Staining Kit for RCC

  2026-09-02

  Separate chromatin condensation from membrane rupture in one rapid fluorescence workflow for renal cell carcinoma research. The assay is especially useful for comparing syringin, sunitinib, and combination treatments while distinguishing apoptotic morphology from late membrane failure.

• Cycloastragenol Protects Against GIONFH Bone Loss

  2026-09-02

  This in vivo study identifies osteoclast overactivity as a modifiable component of glucocorticoid-induced osteonecrosis of the femoral head and shows that cycloastragenol preserves femoral-head structure in methylprednisolone-treated rats. By combining micro-CT, angiography, histology, gene expression, and protein analysis, the work connects reduced bone resorption with smaller necrotic lesions and improved local blood supply.

• SUCLG1-Driven Histone Succinylation in AML

  2026-09-01

  A 2025 Cell Reports study identifies SUCLG1 as a metabolic regulator of histone succinylation in acute myeloid leukemia. Its findings connect mitochondrial succinyl-CoA handling to BRD4-dependent oncogene transcription, leukemia-cell proliferation, and disease progression in xenograft models.

8031 records 1/536 page Next 12345 下5页 Last page